RxDoctor Payments Data

Michael Smith

Family · Johnson City, TNNPI 1003819707

Payments from drug & device makers

$6,749in general payments, 2019–2025

Across 445 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$668
  • Lilly USA, LLC$583
  • AstraZeneca$483
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$310
  • Bayer$259
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$6,749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,749 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$47,467
Medicare patients
132
Services billed
1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$73,067
TrulicityDulaglutide68$70,680
VraylarCariprazine Hcl46$68,053
EliquisApixaban73$55,017
JardianceEmpagliflozin76$47,839
Nurtec OdtRimegepant Sulfate13$25,322
Spiriva HandihalerTiotropium Bromide19$18,642
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$17,885
XareltoRivaroxaban22$17,578
LinzessLinaclotide11$13,399
JanuviaSitagliptin Phosphate11$11,038
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$8,489
Tresiba Flextouch U-100Insulin Degludec13$8,034
Albuterol Sulfate HfaAlbuterol Sulfate212$6,758
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen305$6,492

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess$1,175$81,45257 claims
PfizerEliquis, Nurtec Odt$143$80,33986 claims
Novo NordiskOzempic$668$73,06766 claims
Lilly USA, LLCTrulicity$583$70,68068 claims
Boehringer IngelheimJardiance, Spiriva Respimat$66$54,11688 claims
GSKTrelegy Ellipta$183$17,88525 claims
Johnson & JohnsonXarelto$68$17,57822 claims
MerckJanuvia$117$11,03811 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$250$5,62712 claims
NovartisEntresto$173$4,84929 claims
Sanofi-aventis U.S. LLCLantus$30$2,47914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →